Skip Ribbon Commands
Skip to main content

Hepatitis B Trial

Professor Lim Seng Gee (Senior Consultant, Division of Gastroenterology and Hepatology) is leading a study that seeks to find out if Hepatitis B patients carrying a low amount of the markers of the viral infection have the best chances of being cured by stopping medication. 

Hepatitis B, which is a potentially deadly viral infection that affects the liver, is the most common cause of liver diseases and liver cancer. The trial aims to find out the possibility of recovery after halting patients' oral antiviral treatment.

Interested parties can call 6772 4447 for more information.

Click on the following links to read more about the study:

Print

Online

Broadcast